IRIS

Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis / Olivera, Pablo A; Lasa, Juan S; Bonovas, Stefanos; Danese, Silvio; Peyrin-Biroulet, Laurent. - In: GASTROENTEROLOGY. - ISSN 0016-5085. - 158:6(2020), pp. 1554-1573.e12. [10.1053/j.gastro.2020.01.001]

Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis

Danese, Silvio;
2020-01-01
2020
Inglese
158
6
1554
1573.e12
2-s2.0-85082139591
WOS:000534228500007
IBD
Immunosuppression
NMSC
Small Molecule
Arthritis
Rheumatoid
Azetidines
Herpes Zoster
Heterocyclic Compounds
3-Ring
Humans
Incidence
Inflammatory Bowel Diseases
Janus Kinase Inhibitors
Janus Kinases
Piperidines
Placebos
Psoriasis
Pyridines
Pyrimidines
Pyrroles
Randomized Controlled Trials as Topic
Spondylitis
Ankylosing
Sulfonamides
Survival Analysis
Treatment Outcome
Triazoles
Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis / Olivera, Pablo A; Lasa, Juan S; Bonovas, Stefanos; Danese, Silvio; Peyrin-Biroulet, Laurent. - In: GASTROENTEROLOGY. - ISSN 0016-5085. - 158:6(2020), pp. 1554-1573.e12. [10.1053/j.gastro.2020.01.001]
none
5
info:eu-repo/semantics/article
262
Olivera, Pablo A; Lasa, Juan S; Bonovas, Stefanos; Danese, Silvio; Peyrin-Biroulet, Laurent
1 Contributo su Rivista::1.1 Articolo in rivista
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/119632
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 293
  • ???jsp.display-item.citation.isi??? 266
social impact